BPC-157 5mg + TB-500 5mg (BB10) is a compound lyophilized product composed of two research peptides, primarily used for research on tissue repair, cell signaling, and regenerative biological mechanisms.
BB10 (BPC-157 5mg + TB-500 5mg) is a compound peptide research product composed of two bioactive peptides with different structures: BPC-157 and TB-500. BPC-157 is a 15-peptide compound, while TB-500 is derived from a research fragment related to thymosin β4. Because of their different molecular structures and research focuses, this compound product is often used to explore synergistic effects between peptides, cell migration mechanisms, tissue-related biological processes, and cell repair signaling pathways. The product is typically supplied as a white to off-white lyophilized powder and its quality is evaluated by HPLC and LC-MS.
BPC-157 + TB-500 (BB10) is primarily used in basic life sciences and regenerative medicine research. Researchers utilize this complex peptide to study cell migration, tissue repair mechanisms, angiogenesis-related signaling, inflammatory response mechanisms, and extracellular environment regulation. By combining two research peptides with different structures, it can be used to explore the potential impact of peptide complex systems on cell biological processes.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Acetate BPC-157 (BC10) is a synthetic polypeptide research compound composed of ...
BPC-157 10mg + TB-500 10mg (BB20) is a compound research peptide product compose...
TB-500 (Thymosin β4 Acetate, BT10) is a thymosin β4-related research peptide u...
Contact our team for volume discounts and custom peptide services
Weitai Bio is a national high-tech enterprise specializing in the research, development, production, and sales of peptide drugs. It is also a leading global supplier of high-quality peptides, consistently focusing on peptide drugs and small nucleic acid fields.